.

ISSN 2063-5346
For urgent queries please contact : +918130348310

Assessment of metabolic syndrome in type 2 diabetes mellitus

Main Article Content

Dr. Kolla Gautham, Dr. Anudeep Gaddam
» doi: 10.48047/ecb/2022.11.12.013

Abstract

Patients who suffer from diabetes and who have hyperglycemia are at a greater risk of having complications, which contributes to their overall morbidity. People who have diabetes have a higher risk of experiencing complications due to a mix of risk factors, some of which may be changed and others of which cannot. The phrase "metabolic syndrome," which refers to a cluster of risk variables that may accurately predict cardiovascular disease and type 2 diabetes mellitus, is attracting a lot of attention these days. Some of the primary features of this illness include hypertriglyceridemia, low levels of high density lipoprotein cholesterol (HDL), central adiposity (abdominal) obesity, hypertension, and related insulin resistance/glucose intolerance (hyperinsulinemia). It is associated with a three to five times increased likelihood of developing type 2 diabetes mellitus, a condition that has now reached major proportions in a majority of places across the world. The goal of this study is to identify the most significant risk factors for metabolic syndrome (MetS) that place these groups at a higher risk for developing prediabetes and type 2 diabetes mellitus, as well as the impact that MetS has on the progression of diabetes. In addition, the researchers want to determine how MetS affects the progression of diabetes

Article Details